These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3857181)

  • 1. Phase II study of epirubicin in advanced adenocarcinoma of the pancreas.
    Wils J; Bleiberg H; Blijham G; Dalesio O; Duez N; Lacave A; Splinter T
    Eur J Cancer Clin Oncol; 1985 Feb; 21(2):191-4. PubMed ID: 3857181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with 5-fluorouracil in advanced adenocarcinoma of the pancreas.
    Wils J; Bleiberg H; Dalesio O; Duez N; Blijham G; Planting A; Splinter T; Weber W
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):1017-8. PubMed ID: 3478197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I/II trial of dexverapamil, epirubicin, and granulocyte-macrophage-colony stimulating factor in patients with advanced pancreatic adenocarcinoma.
    Kornek G; Raderer M; Schenk T; Pidlich J; Schulz F; Globits S; Tetzner C; Scheithauer W
    Cancer; 1995 Oct; 76(8):1356-62. PubMed ID: 8620409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.
    Wagener DJ; Hoogenraad WJ; Rougier P; Lusinchi A; Taal BG; Veenhof CH; de Graeff A; Conroy T; Curran D; Sahmoud T; Wils J
    Eur J Cancer; 1996 Jul; 32A(8):1310-3. PubMed ID: 8869091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of 4'-epi-doxorubicin in locally advanced or metastatic gastric cancer.
    Cazap E; Estevez R; Bruno M; Levy D; Algamiz C; Chacon R; Badano C; Romero A; Desimone G; Roca E
    Tumori; 1988 Jun; 74(3):313-5. PubMed ID: 3165228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced carcinoma of the pancreas: phase II study of combined chemotherapy, beta-interferon, and retinoids.
    Recchia F; Sica G; Casucci D; Rea S; Gulino A; Frati L
    Am J Clin Oncol; 1998 Jun; 21(3):275-8. PubMed ID: 9626797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I/II trial of dexverapamil, epirubicin and granulocyte/macrophage-colony-stimulating factor in patients with advanced pancreatic adenocarcinoma.
    Scheithauer W; Kornek G; Raderer M; Koperna-Mach K; Müller C; Karner J; Kastner J; Tetzner C
    J Cancer Res Clin Oncol; 1995; 121 Suppl 3():R7-10. PubMed ID: 8698741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with ifosfamide in advanced adenocarcinoma of the pancreas. EORTC Gastrointestinal Group.
    Wils J; Bleiberg H; Buyse M; Wagener DT; Splinter T; Veenhof C; Herben M; Duez N
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1119-20. PubMed ID: 2759166
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial of epirubicin in gastric cancer.
    Scarffe JH; Kenny JB; Johnson RJ; Owens SE; Giles GR; Leveson SH; Maley WV
    Cancer Treat Rep; 1985 Nov; 69(11):1275-7. PubMed ID: 3867402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epirubicin in advanced endometrial adenocarcinoma: a phase II study of the Grupo Ginecologico Español para el Tratamiento Oncologico (GGETO).
    Calero F; Asins-Codoñer E; Jimeno J; Rodriguez Escudero F; Mendaña J; Iglesias J; Matía F; Armas A; Díaz-Castellanos R; Garzón J
    Eur J Cancer; 1991; 27(7):864-6. PubMed ID: 1834118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase II study of epirubicin on gastric cancer--a cooperative study of the Tokai Cancer Chemotherapy Group].
    Kimura K; Suga S; Kano H; Sakakibara K; Hayashi T; Nakai T; Nagano I; Yokoyama Y; Morise K; Hayakawa M
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2440-5. PubMed ID: 3460530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.
    Iveson T; Donehower RC; Davidenko I; Tjulandin S; Deptala A; Harrison M; Nirni S; Lakshmaiah K; Thomas A; Jiang Y; Zhu M; Tang R; Anderson A; Dubey S; Oliner KS; Loh E
    Lancet Oncol; 2014 Aug; 15(9):1007-18. PubMed ID: 24965569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of single-agent epirubicin and 5-fluorouracil/epirubicin/mitomycin in patients with advanced adenocarcinoma of the pancreas.
    Topham C; Glees J; Coombes RC
    Oncology; 1993 Apr; 50 Suppl 1():78-80. PubMed ID: 8483561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential high-dose methotrexate, 5-fluorouracil, and doxorubicin for treatment of advanced pancreatic cancer.
    Scheithauer W; Funovics J; Mueller C; Ludwig H
    J Cancer Res Clin Oncol; 1990; 116(2):132-3. PubMed ID: 2324155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung.
    Joss RA; Hansen HH; Hansen M; Renard J; Rozencweig M
    Eur J Cancer Clin Oncol; 1984 Apr; 20(4):495-9. PubMed ID: 6327315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial chemotherapy of advanced pancreatic cancer: a single center experience.
    Milandri C; Calzolari F; Passardi A; Tison C; Giampalma E; Cecconetto L; Golfieri R
    Hepatogastroenterology; 2007 Dec; 54(80):2373-7. PubMed ID: 18265668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of epirubicin in patients with advanced adenocarcinoma of the pancreas.
    Aoki K; Shimada Y; Okazaki N; Tajiri H; Nose H; Okada S; Shirao K; Yokota T; Yoshida S; Saitoh D
    Eur J Cancer; 1992; 28A(8-9):1590. PubMed ID: 1515280
    [No Abstract]   [Full Text] [Related]  

  • 18. A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer.
    Evans TR; Lofts FJ; Mansi JL; Glees JP; Dalgleish AG; Knight MJ
    Br J Cancer; 1996 May; 73(10):1260-4. PubMed ID: 8630289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of high dose epirubicin in combination with cyclophosphamide in patients with advanced breast cancer.
    Levi JA; Beith JM; Snyder RD; Tattersall MH; Bell D; Wheeler H
    Aust N Z J Med; 1995 Oct; 25(5):474-8. PubMed ID: 8588767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
    Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
    Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.